腫瘤免疫學 的英文怎麼說

中文拼音 [zhǒngliúmiǎnyìxué]
腫瘤免疫學 英文
tumor immunology
  • 腫 : Ⅰ名詞（隆起處） swelling Ⅱ動詞（突起） swell; be swollen
  • 瘤 : 名詞（瘤子） tumour
  • 免 : Ⅰ動詞1 （去掉;除掉） dismiss; relieve; remove 2 （避免） avoid; escape; avert 3 （免去） excuse s...
  • 疫 : 名詞（瘟疫） epidemic disease; pestilence
  • 學 : Ⅰ動詞1 （學習） study; learn 2 （模仿） imitate; mimic Ⅱ名詞1 （學問） learning; knowledge 2 （學...
  • 腫瘤 : tumour; core （綿羊體內的）; neoplasm; phyma
  1. As a clinical physician, professor zhang is good at treating internal medical diseases, gynecological diseases, pediatric diseases, especially all kinds of kidney diseases, hemicycle, fever, cough, tumor, immunology diseases and so on

    長年從事中醫養生學研究，承擔國家科技部、自然基金等研究課題，臨床擅長治療各種腎臟疾病、偏頭痛、發熱、咳嗽、腫瘤、免疫類疾病、內分泌疾病、月經病等內婦兒科雜癥。
  2. Tumor immunology and immunotherapy are but one of the exciting areas in cancer research.

    腫瘤免疫學與免療不過是癌瘤研究中這些鼓舞人心的領域之一。
  3. Research of oncological immunology has developed rapidly

    摘要近年來腫瘤免疫學的研究發展較快。
  4. Lenalidomide is a noel immune modulating, non - chemotherapy, cancer drug that is chemically similar to thalidomide, but is more potent in the laboratory and appears to lack some of the more common side effects of thalidomide

    來那度胺是一種新型的免疫調節劑用來治療腫瘤，它是非化療藥物，化學結構與反應停相似，但是在實驗室研究效果更好，副作用更少。
  5. Photodynamic therapy - induced anti - tumor immune response : a research progress

    光動力學療法誘導抗腫瘤免疫反應研究的進展
  6. Koide n, hamanaka k, igarashi j, et al. cooccurrence of mucoepidermoid carcinoma and squamous cell carcinoma of the esophagus : report of a case [ j ]. surg today, 2000, 30 : 636 642

    張永幸，沈瓊，喬思傑，等. 20例食管黏液表皮樣癌組織化學和免疫組織化學觀察組織發生學探討[ j ] .河南腫瘤學雜志， 1995 ， 8 ： 8789
  7. At present, in an attempt to stimulate specific antitumor immunity, experimental models and clinical studies are currently evaluating the potent antigen - presenting capacity of dc combined with single or multiple tumor antigen epitopes. however, there are several problems in utilizing pulsing dc with synthetic immunodominant peptides from identified antigens. 1 ) the potential induction of tolerance ; 2 ) the need to determine the patient ' s hla haplotype, the limitation of therapy to patients whose tumors express defined specific tumor antigens in the context of the correct hla phenotype, the unavailability of peptides for all hla haplotypes ; 3 ) the lack of cd4 help cell - related epitopes for most antigens ; and 4 ) the ctl resulting from such protocols have a good in vitro capacity to kill peptide - pulsed target cells but only a modest capacity to kill tumor cells

    但是，學者們發現這一療法存在著如下的缺陷：單一ctl表位抗原肽的應用其抗腫瘤作用弱於多種腫瘤抗原的聯合應用，且有誘導免疫耐受的潛在危險，有時反而會促進腫瘤的生長；事先需對患者的hla單倍型進行鑒定，以確定ctl表位與hla單倍型是否匹配，目前尚缺乏能與所有hla單倍型相匹配的ctl表位，從而限制了這一療法的應用；這一療法所產生的ctl在體外能有效殺傷經腫瘤抗原肽共孵育過的靶細胞，但對腫瘤細胞的殺傷能力較弱：這種l表位抗原肽缺乏cd4汀h細胞相關的表位，因此，不能誘導有效的th細胞免疫應答。
  8. Objective from 1990s, the successful cloning of many tumor antigen genes of human kind has driven the development of tumor immunology enormously. and so does it to the application of tumor immunodiagno sties and immunotherapy

    目的： 20世紀90年代以來，多種人類腫瘤抗原基因克隆的成功，大大推動了腫瘤免疫學理論的發展，也促進了腫瘤免疫診斷和免疫治療的應用。
  9. To circumvent these deficits, novel antigen - delivery systems utilizing cytokine gene - modified tumor cells and dc or fusion of dc with tumor cells have resulted in induction of antitumor immunity. however, this u approach is difficult in some cases ( for example in breast cancer ) because only rarely has it been possible to isolate enough viable tumor cells from an individual to prepare the vaccine

    為了克服上述缺陷，有學者採用滅活的腫瘤細胞、腫瘤抗原提取物（包括腫瘤細胞裂解物、 it na和洗脫肽等）沖擊致敏dc或將腫瘤細胞與dc融合后再回輸體內以激發機體的抗腫瘤免疫應答，也取得了較好的療效。
  10. Objective to study the characteristics of morphology and immunohistochemistry of basal cell hyperplasia and tumor of prostate in order to provide evidences for its diagnostis

    目的探討前列腺基底細胞增生和腫瘤的形態學和免疫組化特徵，提供診斷依據。
  11. Conclusions basal cell hyperplasia and tumors have different features of morpholoy and immunohistochemistry in constract to that of secretory cells, and based on these fertures 6 types were categorized

    結論基底細胞增生和腫瘤具有與分泌細胞不同的形態學和免疫組化反應特徵，其特徵可表現為6型。
  12. It is well known that tumor necrosis factor a ( tnfa ) can play very different character in defence mechnism of body and pathologic injury, in which it can inhibit or kill tumor cell, and induce inflammation against infection ; on the other hand, tnfa can be as a very important mediator to cause some serious pathologic processes such as septic shock, gvhr and some autoimmune diseases

    腫瘤壞死因子（ tumornecrosisfactor ， tnf ）具有對某些惡性腫瘤的抑制或殺傷作用，也是致內毒素性休克、急性移植物抗宿主病及一些自身免疫病的重要效應因子，因此tnf的改造和tnf拮抗劑的研究受到各國學者的重視。
  13. The location, the histopathologic and immunohistochemical appearance of the tumor, and the time elapsed since the initial treatment make it probable that this tumor is associated with prior radiation treatment

    由其腫瘤位置、組織病理及免疫組織化學表現、最初治療結束至發病時間間隔等特性分析，此惡性纖維組織細胞瘤可能與先前之放射治療有密切關系。
  14. In this review, recent advances in the cytopathology of gynecological tumors, ovarian borderline tumors, two types of endometrial cancer, vulvovaginal soft tissue tumors and the role of immunohistochemistry in the diagnosis of gynecological tumors are discussed

    摘要本文結合近年來婦科病理診斷領域的新進展，從婦科細胞學、交界性腫瘤診斷進展、子宮內膜癌的分型、外陰和陰道間葉源性腫瘤、免疫組化在婦科病理診斷中的應用等方面進行了綜述。
  15. Co 2 incubator is an advanced instrument for culture of cells, tissue and bacteria. it is a necessary key apparatus for making scientific researches in immunology, oncology, genetics and biological engineering. itis also widely applicable to the research and prosucon work in medical science, microbiology agricultural science and harmacology

    Co 2培養箱是細胞.組織.細菌培養的一種先進儀器.是開展免疫學.腫瘤學.遺傳學.及生物工程所必須的關鍵設備，廣泛應用於醫學.微生物.農業科學藥物學的研究和生產
  16. The research fields covers chemical synthesizing, microbiology ， biotechnology, the extraction separation and pharmaceutics and the products aiming to cure people ' s disease are related to anti tumor, cardiovascular system, anti - infective, antiphrastic, endocrine system, immunosuppression, anti depress, etc

    研發領域涵蓋化學合成、微生物發酵、生物技術、天然植物提取及制劑開發等多個方面，產品治療領域涉及抗腫瘤、心血管系統、抗感染、抗寄生蟲、內分泌調節、免疫抑制、抗抑鬱等。
  17. Recombinant il - 2 is used as a clinical immune preparation to several kinds of tumors. it can affiliate the basal secretion of acth, prl, tsh in tissue pieces of pituitary, having a function on the secretion of lh, fsh, gh simultaneously

    臨床上用大劑量的重組il - 2對腫瘤進行免疫治療， il - 2可第四軍醫大學碩士學位論文以促進垂體組織塊acth 、 pgy和tsh的基礎分泌，對lh 、 fsh和gh的分泌也有作用。
  18. These conventional approaches cannot be selectively targeted to the tumor cells and completely eradicate them, this may account for the development of recurrence and metastasis of gastric cancer due to the existence of residual tumor cells ; in addition, as to some kinds of conventional approaches, such as chemical therapy, their tumoricidal effects also could cause damage to some other normal tissues / cells and undermine the function of immune system in patients with gastric cancer

    目前，臨床上的?些常規方法，包括外科手術的、化學的及物理的治療手段，對絕大多數中晚期胃癌的療效均不理想。其原因在於這些常規方法對癌細胞缺乏選擇性，並不能特異性地殺傷癌細胞，勢必造成殘存癌細胞引起的腫瘤復發和轉移。某些常規方法，如化療，在殺傷癌細胞的同時，也會造成機體正常組織的損傷並削弱機體的免疫機能。
  19. We reviewed the advances of detective methods of new immunology and gene on gastric carcinoma metastasis, and discussed the combinative application of multi - markers detection

    綜述了有關胃癌浸潤轉移的免疫分子和基因的研究現狀，提出了新的免疫學診斷指標在預測腫瘤轉移方面的應用，以及多項指標聯合檢測的可能性。
  20. Ronald mk, steven m, banks bm, et al. phenotypic characterization of murine tumor - infiltrating lymphocytes. j immunol, 1991 ; 146 : 2043

    李彪如，童善慶，朱佑明，等.一種高活力分離腫瘤浸潤性淋巴細胞方法的建立.免疫學雜志， 1994 ; 10 （ 1 ） : 44
分享友人
分享到 Line

分享到臉書